Collectively, this study indicated that MAP3K7 expression is stimulated by TNF-α and IL-1β and, in turn, activates NFκB 1, which has the ability to prolong Bcl-2-mediated CD4+ T cell survival in NMO patients. This evidence concerns the gene MAP3K7 and neuromyelitis optica.